Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management
Carla Maria Boquimpani; André Neder Ramires Abdo; Denise Pires Martins; Luciana Britto de Abreu Lima; Mayde Seadi Torriani; Israel Bendit;
Hematol Transfus Cell Ther. 2021;43:50-7
PDCD1 VARIANTS ARE INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA
Matheus Yung Perin; Daniele Daiane Affonso; Carlos Takahiro Chone; Gustavo Jacob Lourenço; Carmen Silvia Passos Lima;
Hematol Transfus Cell Ther. 2025;47 Supl 1:
Optimization of hydroxyurea in sickle cell disease in Brazil
Clarisse Lobo; Ana Cristina Silva-Pinto; Rodolfo Delfini Cançado;
10.1016/j.htct.2025.103826